Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
Bureaucrats upending NIH
The National Institutes of Health (NIH) faces a revolt by its employees over new, draconian conflict-of-interest rules. They ban all consulting (paid or unpaid) for…
Op-Eds
Misnamed Activists Are Thorns In Rose Of Agbiotech Foods
In a spin-dominated world where activists claim—often on the flimsiest of data—that this, that or the other thing causes cancer or threatens the…
News Release
Career Scientist Nominated as EPA Head
Contact for Interviews: <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Richard Morrison, 202.331.2273 …
Op-Eds
Dying for Regulatory Reform
Full article available in pdf format Congress has a long and ignoble history of exaggerated legislative responses to perceived health…
Op-Eds
Science Goes Tabloid: In scientific journals, if it bleeds, it leads
In the United Kingdom, most of the respected broadsheet newspapers have cut costs and increased circulation by adding a tabloid edition. Some argue that…
Op-Eds
Travesties of Regulation: Harmful U.N. policies.
Former Federal Reserve Board chairman Paul Volcker, who heads the inquiry into corruption in the United Nations' defunct oil-for-food program, has just issued…